LANDONI, Luca
 Distribuzione geografica
Continente #
NA - Nord America 6.149
EU - Europa 6.006
AS - Asia 4.008
SA - Sud America 568
Continente sconosciuto - Info sul continente non disponibili 207
AF - Africa 135
OC - Oceania 13
Totale 17.086
Nazione #
US - Stati Uniti d'America 5.969
RU - Federazione Russa 2.449
SG - Singapore 1.522
CN - Cina 1.188
IT - Italia 1.089
GB - Regno Unito 705
BR - Brasile 445
DE - Germania 373
VN - Vietnam 357
HK - Hong Kong 338
SE - Svezia 330
IE - Irlanda 268
FR - Francia 265
FI - Finlandia 152
KR - Corea 114
BD - Bangladesh 105
CA - Canada 102
IN - India 90
NL - Olanda 81
JP - Giappone 65
ES - Italia 57
UA - Ucraina 48
MX - Messico 45
TR - Turchia 39
PL - Polonia 34
AR - Argentina 32
ZA - Sudafrica 29
IQ - Iraq 27
NG - Nigeria 25
AT - Austria 24
ID - Indonesia 24
BE - Belgio 20
CO - Colombia 20
PK - Pakistan 20
CZ - Repubblica Ceca 19
NP - Nepal 19
CL - Cile 18
VE - Venezuela 18
TG - Togo 15
LT - Lituania 14
UZ - Uzbekistan 14
EC - Ecuador 13
EG - Egitto 12
PH - Filippine 12
BJ - Benin 11
MA - Marocco 11
SA - Arabia Saudita 11
AU - Australia 10
CH - Svizzera 9
TN - Tunisia 9
AZ - Azerbaigian 8
LV - Lettonia 8
RO - Romania 8
DK - Danimarca 7
IL - Israele 7
IR - Iran 7
JO - Giordania 7
PE - Perù 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
HR - Croazia 6
JM - Giamaica 6
KE - Kenya 6
MY - Malesia 6
PY - Paraguay 6
GR - Grecia 5
GT - Guatemala 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
ET - Etiopia 4
HU - Ungheria 4
BO - Bolivia 3
HN - Honduras 3
KG - Kirghizistan 3
RS - Serbia 3
BG - Bulgaria 2
BH - Bahrain 2
DZ - Algeria 2
EU - Europa 2
GA - Gabon 2
KZ - Kazakistan 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
QA - Qatar 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
Totale 16.857
Città #
Moscow 905
Singapore 855
Ashburn 767
Dallas 679
Chandler 646
San Jose 562
Southend 548
Hong Kong 334
Verona 332
Dublin 257
Beijing 231
Council Bluffs 215
New York 189
The Dalles 157
Jacksonville 156
Los Angeles 149
Munich 134
Ho Chi Minh City 130
Ann Arbor 102
Woodbridge 101
Helsinki 82
Hanoi 81
Lawrence 75
Princeton 75
Santa Clara 72
Milan 69
Jinan 67
Wilmington 66
Houston 60
São Paulo 58
Shenyang 55
Rome 53
Tokyo 52
Nanjing 50
Redmond 48
Orem 44
Buffalo 41
Turku 41
Bologna 40
Redondo Beach 40
Sindelfingen 40
Tianjin 39
London 38
Montreal 37
Amsterdam 36
Columbus 34
Phoenix 34
Hebei 33
Denver 32
Haikou 30
Seattle 30
Toronto 29
Warsaw 29
Washington 29
Chennai 28
Stockholm 28
Atlanta 27
Hangzhou 27
Taiyuan 26
Abuja 25
Ningbo 24
Guangzhou 23
Mexico City 23
Chicago 22
Changsha 21
Johannesburg 21
Zhengzhou 21
Brussels 20
Nanchang 20
Seoul 20
Brooklyn 19
Frankfurt am Main 18
Belo Horizonte 17
Poplar 17
Mumbai 16
Redwood City 16
Rio de Janeiro 16
Da Nang 15
Lomé 15
Manchester 15
Nuremberg 15
San Francisco 15
Vienna 15
Barnet 14
Boardman 14
Brno 14
City of London 14
Memphis 14
Taizhou 14
Boston 13
Fairfield 13
Falkenstein 13
Tashkent 13
Florence 12
Kathmandu 12
Shanghai 12
Charlotte 11
Cotonou 11
Haiphong 11
Paris 11
Totale 9.889
Nome #
ULCERE DIFFICILI DEGLI ARTI INFERIORI: UN CASO DI ERITEMA INDURATO DI BAZIN 395
Somatostatin analogs for resectable pancreatic neuroendocrine tumors in high-risk surgical patients: Data from a single-center cohort 301
Whole-genome landscape of pancreatic neuroendocrine tumours 286
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 261
A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia 253
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 253
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 246
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 243
CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms 242
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 240
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 238
3D-CT texture analysis of neuroendocrine pancreatic neoplasms 237
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 235
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 222
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 222
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 217
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 216
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 213
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 212
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 211
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 211
ANOMALIE ASSOCIATE DELL'APPENDICE VERMIFORME. DESCRIZIONE E DISCUSSIONE DI UN CASO 209
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 208
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 206
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 202
Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment 196
Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections 196
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 196
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 195
Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage 192
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 191
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms 190
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 189
Liver Tumor Burden in Pancreatic Neuroendocrine Tumors: CT Features and Texture Analysis in the Prediction of Tumor Grade and 18F-FDG Uptake 186
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 183
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 182
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 181
Endoscopic placement of pancreatic stent for "Deep" pancreatic enucleations operative technique and preliminary experience at two high-volume centers 179
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 178
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors 178
Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk Stratification 177
Comparison between EUS-guided fine-needle aspiration cytology and EUS-guided fine-needle biopsy histology for the evaluation of pancreatic neuroendocrine tumors 175
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 175
TREATMENT OF SIX HEPATIC ARTERY ANEURYSMS 172
Endoscopic Ultrasound Features Associated with Malignancy and Aggressiveness of Nonhypovascular Solid Pancreatic Lesions: Results from a Prospective Observational Study 171
Imaging presentation of pancreatic neuroendocrine neoplasms 169
Long term outcome after minimally invasive and open Warshaw and Kimura techniques for spleen-preserving distal pancreatectomy: International multicenter retrospective study 168
Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study 168
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 167
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 165
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 165
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 165
Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center 164
Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors 163
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 163
Histogram analysis of ADC maps: assessment of intra-tumoral heterogeneity and correlation with the biological behavior of pancreatic neuroendocrine neoplasms 163
An Antibiotic Stewardship Program in Pancreatic Surgery 163
Laser Treatment of Pancreatic Cancer with Immunostimulating Interstitial Laser Thermotherapy Protocol: Safety and Feasibility Results From Two Phase 2a Studies 161
Love (Pancreatic Surgery) in the Time of Cholera (COVID-19) 159
401 consecutive minimally invasive distal pancreatectomies: lessons learned from 20 years of experience 159
Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts 158
Digital Subtraction of Magnetic Resonance Images Improves Detection and Characterization of Pancreatic Neuroendocrine Neoplasms 157
Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms 157
Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial 155
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 153
Long-term organoid culture of a small intestinal neuroendocrine tumor 152
Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome 151
Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium 150
Robotic Dual-Console Distal Pancreatectomy: Could it be Considered a Safe Approach and Surgical Teaching even in Pancreatic Surgery? A Retrospective Observational Study Cohort 150
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 147
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 146
Assessment of difficulty in laparoscopic distal pancreatectomy: a modification of the Japanese difficulty scoring system - A single-center high-volume experience 145
Pancreatic surgery during COVID-19 pandemic: major activity disruption of a third-level referral center during 2020 144
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 141
Hemodynamics and remodeling of the portal confluence in patients with malignancies of the pancreatic head: a pilot study towards planned and circumferential vein resections 141
Differentiation of pancreatic neuroendocrine tumor grade comparing 3D CT texture analysis and relative CT enhancement ratios 140
Negative pressure wound therapy for prevention of surgical site infection in patients at high risk after clean-contaminated major pancreatic resections: A single-center, phase 3, randomized clinical trial 140
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 136
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 129
Synchronous superior mesenteric-portal vein resection during pancreatectomy for T3 head adenocarcinoma: Perioperative outcomes and prognostic implications of histologically confirmed venous infiltration 128
Thirty-day prevalence and clinical impact of fluid collections at the resection margin after distal pancreatectomy: Follow-up of a multicentric randomized controlled trial 126
Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection 124
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring 124
Pancreatic surgery is a safe teaching model for tutoring residents in the setting of a high-volume academic hospital: a retrospective analysis of surgical and pathological outcomes 123
Outcomes of patients undergoing elective liver and pancreas cancer surgery during the SARS-CoV-2 pandemic: an international, multicentre, prospective cohort study 122
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 120
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres) 118
Mortality and pulmonary complications in emergency general surgery patients with COVID-19: A large international multicenter study 115
Transcriptome analysis of primary sporadic neuroendocrine tumours of the intestine identified three different molecular subgroups 108
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 108
Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study 107
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size 104
Author response to: Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 102
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 102
Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma 96
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 96
Reappraisal of a 2-Cm Cut-Off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study 74
Pancreatic stump perfusion assessment using indocyanine green fluorescence and its impact on postoperative pancreatic fistula: A systematic review and meta-analysis 46
Postoperative Fluid Collections Following Left Pancreatectomy: Urgent Need for a Standardized Definition. A Systematic Review and Meta-Analysis 31
From Open to Robot-Assisted Pancreatoduodenectomy: What RCTs Really Show 31
Totale 17.020
Categoria #
all - tutte 59.734
article - articoli 57.164
book - libri 0
conference - conferenze 2.570
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.468


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022669 0 202 30 74 30 16 12 35 44 14 58 154
2022/20231.757 92 240 139 323 108 443 39 108 183 16 39 27
2023/20241.143 32 76 121 120 106 221 88 57 21 50 196 55
2024/20252.503 124 128 141 388 135 113 152 141 301 173 240 467
2025/20268.302 515 372 664 1.331 2.153 533 677 479 692 520 141 225
2026/2027466 273 193 0 0 0 0 0 0 0 0 0 0
Totale 17.086